Balancing diuretic therapy in heart failure: Loop diuretics, thiazides, and aldosterone antagonists

Congestive Heart Failure

Volumn 8, Issue 6, 2002, Pages 307-312

  Paul, Sara ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BUMETANIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

BREAST TENDERNESS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIURETIC THERAPY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG POTENCY; EDEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HAIR GROWTH; HEADACHE; HEART ARRHYTHMIA; HEART INDEX; HENLE LOOP; HUMAN; LIBIDO DISORDER; NERVOUSNESS; PATIENT COUNSELING; RASH; REVIEW; SIDE EFFECT; SODIUM INTAKE; SODIUM RETENTION; VERTIGO; WATER RETENTION;

EID: 0036858602     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.00700.x     Document Type: Review

References (38)

1. Starling E. On the absorption of fluids from the connective tissue spaces. J Physiol (London). 1896;19:312-326.
2. Starr I. Role of the "static blood pressure" in abnormal increments of venous pressure, especially in heart failure. II. Clinical and experimental studies. Am J Med. Sci. 1940;199:40-55.
3. Starr I, Rawson A. Role of the "static blood pressure" in abnormal increments of venous pressure, especially in heart failure. I. Theoretical studies on an improved circulation schema whose pump obeys Starling's law of the heart. Am J Med Sci. 1940;199:27-39.
4. Warren J, Stead E. Fluid dynamics in chronic congestive failure. Arch Intern Med. 1944;73:138-147.
5. Merrill A. Edema and decreased renal blood flow in patients with chronic congestive heart failure. Evidence of "forward failure" as the primary cause of edema. J Clin Invest. 1946;25:389-400.
6. Merrill A. Mechanisms of salt and water retention in heart failure. Am J Med. 1949;6:357-367.
7. Anand I. Pathogenesis of salt and water retention in the congestive heart failure syndrome. In: Poole-Wilson P, Colucci W, Massie B, et al., eds. Heart Failure: Scientific Principles and Clinical Practice. New York, NY: Churchill Livingstone; 1997: 155-171.
8. Anand I, Ferrari R, Kalra G, et al. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299-305.
9. Stanton B, Kaissling B. Adaptation of distal tubule and collecting duct to increased sodium delivery, II. Sodium and potassium transport. Am J Physiol. 1988;255:F1269-F1275.
10. Rose B. Diuretics. Kidney Int. 1991;39:336-352.
11. Osborn J, Holdaas H, Thames M, et al. Renal adrenoreceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog. Circ Res. 1983;53:298-305.
12. Stanton B. Regulation of sodium and potassium transport by mineralocorticoids. Semin Nephrol. 1987;7:82-90.
13. Liu F, Cogan M. Angiotensin II: a potent regulator of acidification in the rat early proximal convoluted tubule. J Clin Invest. 1987;80:272-275.
14. Dikshit K, Vyden J, Forrester J, et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Eng J Med. 1973; 288:1087-1090.
15. Pickkers P, Dormans T, Russell F, et al. Direct vascular effects of furosemide in humans. Circulation. 1997;96:1847-1852.
16. Fujimura A, Ebihara A. Role of angiotensin II in renal prostaglandin E production after furosemide administration. Hypertension. 1988;11:491-494.
17. Johnston G, Hiatt W, Nies A, et al. Factors modifying the early nondiuretic vascular effects of furosemide in man: The possible role of renal prostaglandins. Circ Res. 1983;53:630-635.
18. Bourland W, Day D, Williams H. The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther. 1977;202:221-229.
19. Edwards R. Effects of prostaglandins and vasoconstrictor action in isolated renal arterioles. Am J Physiol. 1985;248:F779-F784.
20. Scharschmidt L, Simonson M, Dunn M. Glomerular prostaglandins. AII, and non-steroidal anti-inflammatory drugs. Am J Med. 1986;81:30-42.
21. Brater D. Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J Pharmacol Exp Ther. 1979;210:386-390.
22. Ellison D. Diuretic drugs and the treatment of edema: from clinic to bench and back again. Am J Kidney Dis. 1994;23:623- 643.
23. Francis G, Siegel R, Goldsmith S, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985;103:1-6.
24. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
25. Rose B. Treatment of refractory edema. Up To Date CD ROM. 2000;8:1-4.
26. Kramer B, Schweda F, Riegger G. Diuretic treatment and diuretic resistance in heart failure. Am J Med. 1999;106:90-96.
27. Brater D, Day B, Burdette A, et al. Bumetanide and furosemide in heart failure. Kidney Int. 1984;26:183-189.
28. Vasko M, Cartwright D, Knochel J, et al. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med. 1985;102:314-318.
29. Brater D, Seiwell R, Anderson S, et al. Absorption and disposition of furosemide in congestive heart failure. Kidney Int. 1984;22:171-176.
30. Dormans T, van Meyel J, Gerlag P, et al. Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion. J Am Coll Cardiol. 1996;28:376-382.
31. Rudy D, Voelker J, Greene P, et al. Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy. Ann Intern Med. 1991;115:360-366.
32. Ring-Larsen H, Henriksen J, Wilken C, et al. Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effect of posture. Br Med J. 1986;292:1351-1353.
33. Wollam G, Tarazi R, Bravo E, et al. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med. 1982;72:929-938.
34. Marone C, Muggli W, Lahn W, et al. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur J Clin Invest. 1985;15:253-257.
35. Oster J, Epstein M, Smoller S. Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med. 1983;99:405-406.
36. Richards A, Nicholls M. Aldosterone antagonism in heart failure. Lancet. 1999;354:789-790.
37. Pitt B, Zannad F, Remme W et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Eng J Med. 1999;341:709-717.
38. Heart Failure Society of America. Guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction: Pharmacological approaches. Congest Heart Fail. 2000;6:11-38.